Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen.
Smolarz
B Gabriel
BG
Ross
Jacqueline
J
Sachinwalla
Eric
E
Marcus
Akiva
A
Abazia
Daniel T
DT
D000081:Acetamides / Q000627:therapeutic use; D000082:Acetaminophen / Q000009:adverse effects* / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy; D004155:Diphenhydramine / Q000627:therapeutic use; D004338:Drug Combinations; D015738:Famotidine / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D023303:Oxazolidinones / Q000627:therapeutic use; D010098:Oxycodone / Q000009:adverse effects* / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D013207:Staphylococcal Skin Infections / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects; D016896:Treatment Outcome; D014640:Vancomycin / Q000009:adverse effects* / Q000627:therapeutic use
D000081:Acetamides; D000700:Analgesics; D000890:Anti-Infective Agents; D004338:Drug Combinations; D023303:Oxazolidinones; C514822:oxycodone-acetaminophen; D000082:Acetaminophen; D015738:Famotidine; D014640:Vancomycin; D005665:Furosemide; D004155:Diphenhydramine; D010098:Oxycodone; D000069349:Linezolid